Allergy Therapeutics PLC
LSE:AGY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Allergy Therapeutics PLC
Cash Interest Paid
Allergy Therapeutics PLC
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Cash Interest Paid
£1.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash Interest Paid
£679m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash Interest Paid
$1.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash Interest Paid
$83m
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
5%
|
|
|
Animalcare Group PLC
LSE:ANCR
|
Cash Interest Paid
£627k
|
CAGR 3-Years
15%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Cash Interest Paid
£8.8m
|
CAGR 3-Years
44%
|
CAGR 5-Years
29%
|
CAGR 10-Years
24%
|
|
Allergy Therapeutics PLC
Glance View
Allergy Therapeutics Plc is a biotechnology company. The company is headquartered in Worthing, West Sussex and currently employs 601 full-time employees. The company went IPO on 2004-10-11. The firm is focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines. Its segments include Central Europe, which include segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes Italy, Spain and Other; the United Kingdom, and Rest of World. The company sells both injectable and sublingual allergen-specific immunotherapies. Its pipeline candidates include Grass MATA MPL, Birch MATA MPL, Ragweed MATA MPL, Trees MATA MPL and Peanut SCIT. Its vaccine candidates outside allergy include disease areas, including cancer, asthma, atopic dermatitis and psoriasis. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Venomil, VLP Peanut and ImmunoBON.
See Also
What is Allergy Therapeutics PLC's Cash Interest Paid?
Cash Interest Paid
1.1m
GBP
Based on the financial report for Dec 31, 2025, Allergy Therapeutics PLC's Cash Interest Paid amounts to 1.1m GBP.
What is Allergy Therapeutics PLC's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
12%
Over the last year, the Cash Interest Paid growth was -37%. The average annual Cash Interest Paid growth rates for Allergy Therapeutics PLC have been 29% over the past three years , 12% over the past five years , and 12% over the past ten years .
